Search Results - Huitema, A.D

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    MO2 Impact of Structural Assumptions on Cost-Effectiveness Outcomes: Towards a Standardized Cost-Effectiveness Model for Adjuvant Breast Cancer Therapies

    MO2 Impact of Structural Assumptions on Cost-Effectiveness Outcomes: Towards a Standardized Cost-Effectiveness Model for Adjuvant Breast Cancer Therapies by Frederix, G.W, Van hasselt, J.G, Schellens, J.H, Hövels, A.M, Huitema, A.D, Raaijmakers, J.A, Severens, J

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PRM46 Development of a Framework for Cost-Effectiveness Analysis Cohort Simulation Using an Ordinary Differential Equation Solver Algorithm in R

    PRM46 Development of a Framework for Cost-Effectiveness Analysis Cohort Simulation Using an Ordinary Differential Equation Solver Algorithm in R by Frederix, G.W, van Hasselt, J.G, Severens, J.L, Hövels, A.M, Huitema, A.D, Raaijmakers, J.A, Schellens, J.H

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Pharmacokinetics, Clinical Efficacy and Safety of Plasma-Derived Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary and Acquired Angioedema

    Pharmacokinetics, Clinical Efficacy and Safety of Plasma-Derived Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary and Acquired Angioedema by Hofstra, J.J., van Twuyver, E., Kleine-Budde, I., Choi, C.W., Levi, M., Leebeek, F.W.G., de Monchy, J.G.R., Ypma, P.F., Huitema, A.D., Nienhuis, A., Strengers, P.F.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology

    Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology by van der Kleij, Maud B. A., Guchelaar, Niels A. D., Mathijssen, Ron H. J., Versluis, Jurjen, Huitema, Alwin D. R., Koolen, Stijn L. W., Steeghs, Neeltje

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study)

    Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study) by Overbeek, Joanneke K., Guchelaar, Niels A.D., Mohmaed Ali, Ma Ida, Ottevanger, Petronella B., Bloemendal, Haiko J., Koolen, Stijn L.W., Mathijssen, Ron H.J., Boere, Ingrid A., Hamberg, Paul, Huitema, Alwin D.R., Sonke, Gabe S., Opdam, Frans L., ter Heine, Rob, van Erp, Nielka P.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    CYP3A422 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients

    CYP3A422 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients by van Eerden, Ruben A. G., IJzerman, Nikki S., van Meekeren, Milan, Oomen-de Hoop, Esther, Guchelaar, Niels A. D., Visser, Andrea M. W., Matic, Maja, van Schaik, Ron H. N., de Bruijn, Peter, Moes, Dirk-Jan A. R., Jobse, Pieter A., Gelderblom, Hans, Huitema, Alwin D. R., Steeghs, Neeltje, Mathijssen, Ron H. J., Koolen, Stijn L. W.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancer

    Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancer by Guchelaar, Niels A.D., van Eerden, Ruben A.G., Groenland, Stefanie L., Doorn, Leni van, Desar, Ingrid M.E., Eskens, Ferry A.L.M., Steeghs, Neeltje, van Erp, Nielka P., Huitema, Alwin D.R., Mathijssen, Ron H.J., Koolen, Stijn L.W.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: